Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07734610
PHASE1

A Clinical Trial of Nemtabrutinib in Participants With Severe Kidney Disease (MK-1026-027)

Sponsor: Merck Sharp & Dohme LLC

View on ClinicalTrials.gov

Summary

The purpose of this study is to learn what happens to nemtabrutinib in a person's body when given to participants with severe kidney disease and to healthy participants.

Official title: An Open-Label, Single-Dose Clinical Study to Evaluate the Pharmacokinetics of Nemtabrutinib in Participants With Severe Renal Impairment

Key Details

Gender

All

Age Range

18 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

20

Start Date

2026-08-17

Completion Date

2027-02-01

Last Updated

2026-07-29

Healthy Volunteers

Yes

Interventions

DRUG

Nemtabrutinib

Oral administration